Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.
Stylus Medicine is on a quest to create disease-treating agents for the next generation based on the groundbreaking work of its founders.
Grove Biopharma is a biotechnology company offering a materials science solution to peptide therapeutic challenges.
Solu Therapeutics Platform Company that develops antibody-based medicines using a degradable warhead.
Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases
Ampersand Biomedicines is a multi-product platform that develops programmable medicines that target disease sites precisely.
Persist AI is a biotechnology company that builds long-acting microsphere formulations.
Maxion Therapeutics helps in learning transformative therapies.
Trans Solutions Research and Resource Center empowers transgender and gender communities.
TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.
Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.
Revisto is a pioneer AI-powered technology that simplifies the medical, legal, and regulatory review process for life sciences marketing.
Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
Sunbird Bio is a diagnostics platform developer that aims to give molecular diagnostics with faster outcomes.
Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.
Basys.ai automates the process of prior authorization and utilization management for health plans/payers using an AI-based platform.
NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick’s Medical School.
OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.
Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.
RetiSpec is a medical imaging startup developing an eye scanner for early detection of Alzheimer’s Disease pathology.
Myricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.
Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.
Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics.
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.
Eli Lilly has invested in 169 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Eli Lilly's top investment sectors include Biotechnology, Medical, Therapeutics, Health Care, Biopharma. The firm invests across 23 different industry categories.
Among tracked funding rounds, Aktis Oncology received $175.0M in a Series B round. Eli Lilly's total known invested capital is $11.1B.
Eli Lilly's average investment size is $69.2M across its portfolio of 169 companies.
Recent Eli Lilly portfolio additions include Therini Bio, Stylus Medicine, Grove Biopharma, Solu Therapeutics, Augustine Therapeutics. These companies were founded in 2020 or later.